Nektar Therapeutics (NKTR) P/E (2006 - 2026)
Nektar Therapeutics (NKTR) P/E from Mar 31, 2006 to Jul 21, 2026. The TTM Nektar Therapeutics (NKTR) P/E is -7.57. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Nektar Therapeutics (NKTR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -7.57 | +94.72% |
| 2025 | -3.89 | +143.76% |
| 2024 | -1.60 | +338.56% |
| 2023 | -0.36 | -60.72% |
| 2022 | -0.93 | -80.41% |
| 2021 | -4.73 | -30.75% |
| 2020 | -6.83 | -20.57% |
| 2019 | -8.60 | -194.42% |
| 2018 | 9.10 | -110.82% |
| 2017 | -84.13 | +735.70% |
| 2016 | -10.07 | -63.19% |
| 2015 | -27.35 | -20.62% |
| 2014 | -34.45 | +325.06% |
| 2013 | -8.11 | +63.69% |
| 2012 | -4.95 | -5.44% |
| 2011 | -5.24 | -84.87% |
| 2010 | -34.62 | +310.83% |
| 2009 | -8.43 | -43.50% |
| 2008 | -14.91 | -20.02% |
| 2007 | -18.65 | +58.71% |
| 2006 | -11.75 | N/A |
Comparison Nektar Therapeutics (NKTR) P/E with competitors
Nektar Therapeutics (NKTR) P/E is -7.57.